Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:04:57.539Z.
Consensus retrieved: 2026-10-06T15:28:12.572Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:04:57.539Z.
Quote observation: 2026-10-06T18:00:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 673a23962afa1f964289f2c5c8e96f6ae4ccf5481b64718d91ae2e5553a82c87
FORWARD PE RATIO
N/A
ProQR Therapeutics N.V.
Market Cap
$173.76M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.76M | N/A |
| Journey Medical Corporation (DERM)vs › | $173.52M | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $172.20M | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $172.02M | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.93M | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | N/A |
| MediWound Ltd. (MDWD)vs › | $168.49M | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $179.39M | N/A |
| Nkarta, Inc. (NKTX)vs › | $167.77M | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.30M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in EUR, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
